EUVIMEDEUVIMED entdecken
Crossref

Incidence of Pneumonitis with Concurrent Trastuzumab Emtansine (T-DM1) and Radiotherapy in HER2-Positive Breast Cancer: A retrospective review

Estabrak Jiad, Charlotte Westbury, Nihal Shah

Clinical Oncology · 2026-03 · 51 · 104017

DOI: 10.1016/j.clon.2025.104017 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Oncology, 2026-03. Verfasst von Estabrak Jiad und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Jiad, E., Westbury, C., & Shah, N. (2026). Incidence of Pneumonitis with Concurrent Trastuzumab Emtansine (T-DM1) and Radiotherapy in HER2-Positive Breast Cancer: A retrospective review. Clinical Oncology, 51, 104017. https://doi.org/10.1016/j.clon.2025.104017

Vancouver

Jiad E, Westbury C, Shah N. Incidence of Pneumonitis with Concurrent Trastuzumab Emtansine (T-DM1) and Radiotherapy in HER2-Positive Breast Cancer: A retrospective review. Clinical Oncology. 2026;51:104017. doi:10.1016/j.clon.2025.104017

BibTeX
@article{Jiad2026,
  author = {Jiad, Estabrak and Westbury, Charlotte and Shah, Nihal},
  title = {Incidence of Pneumonitis with Concurrent Trastuzumab Emtansine (T-DM1) and Radiotherapy in HER2-Positive Breast Cancer: A retrospective review},
  journal = {Clinical Oncology},
  year = {2026},
  volume = {51},
  pages = {104017},
  doi = {10.1016/j.clon.2025.104017}
}
Kostenlos starten →